OT Peptide's peptide therapy claims: what the science says

What's this video probably claiming?

@otpept1de runs a channel dedicated to peptide therapy and has built a following around compounds like BPC-157, TB-500, CJC-1295, ipamorelin, GHK-Cu, MK-677, semax, and selank. With 93.9K views and no caption to anchor the claims, this video almost certainly falls into one of the creator's recurring themes: accelerated recovery, growth hormone optimization, cognitive enhancement, or skin repair. Given the creator's pattern, the video likely presents one or more of these peptides as a practical protocol, possibly comparing stacking options or discussing dosing windows. That framing is common in the peptide community and almost always outpaces the clinical evidence. The implicit message in most of these videos is that peptide therapy is both safe and dramatically effective, which is a claim worth stress-testing against the actual literature.

What does the science actually show?

The honest answer is: it depends heavily on which peptide you're talking about, and for most of them, human data is thin. BPC-157 has shown real tissue-repair effects in rodent models, including Sikiric et al. (2018, Current Pharmaceutical Design) reporting accelerated tendon healing, but zero completed human RCTs exist. TB-500 (thymosin beta-4) similarly impresses in animal wound-healing studies, but human evidence is limited to a small MS trial (Goldstein et al., 2012, Annals of the New York Academy of Sciences) that wasn't designed for the recovery use cases being promoted. CJC-1295 combined with ipamorelin does produce measurable GH pulse amplification. Raun et al. (1998, Endocrinology) and Walker et al. (2009, JCEM) documented ipamorelin's GH secretagogue effects, but the downstream muscle and fat outcomes people expect haven't been robustly demonstrated in healthy adults. MK-677, an oral ghrelin mimetic, raised IGF-1 levels by roughly 40-60% over 12 months in Nuttall et al. (1999, JCEM), but also increased fasting glucose and water retention. GHK-Cu shows intriguing collagen synthesis data in vitro. Semax and selank have Soviet-era clinical research from Russia that doesn't meet modern trial standards.

Where does the social media noise diverge from clinical reality?

The gap is wide, and in several specific ways. First, most peptide advocates on TikTok treat rodent data as if it translates directly to human outcomes. It frequently does not. The species gap in pharmacokinetics matters. BPC-157 in a rat receives the compound intraperitoneally at doses that don't map cleanly to subcutaneous human administration. Second, stacking multiple peptides is presented as synergistic without any stacked-combination safety data. Combining a GHRH analog like CJC-1295 with a ghrelin mimetic like ipamorelin is pharmacologically logical, but the long-term IGF-1 elevation effects on cancer risk are not studied in this context. Third, compounded peptides marketed in the US exist in a regulatory gray zone. The FDA removed BPC-157 and TB-500 from the bulk substances list in 2023, making their compounding status legally complicated. Creators rarely mention this. Fourth, cognitive peptides like semax and selank are often discussed as if the Russian clinical trials were rigorous by Western standards. They weren't. Sample sizes were small, controls were inconsistent, and blinding was often inadequate.

What should you actually know?

Peptide therapy is a real and evolving field, but the version circulating on TikTok is a curated show reel. Some of these compounds have genuine mechanistic plausibility and early-stage human data worth watching. Ipamorelin and CJC-1295 have better human pharmacokinetic data than most peptides in this category. GHK-Cu has credible in vitro collagen research. But none of these are FDA-approved for the indications being promoted, compounded versions vary in purity and concentration, and the long-term safety picture for chronic use in healthy adults is genuinely unknown. If you're considering peptide therapy, that conversation should happen with a licensed clinician who can review your labs, not a TikTok creator whose incentive structure rewards engagement over accuracy. FormBlends connects patients with licensed providers who can evaluate whether any of these compounds are appropriate for your specific situation, based on what the evidence actually supports.